Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Mar;147(6):653-60.
doi: 10.1038/sj.bjp.0706491.

Gender differences in the slow delayed (IKs) but not in inward (IK1) rectifier K+ currents of canine Purkinje fibre cardiac action potential: key roles for IKs, beta-adrenoceptor stimulation, pacing rate and gender

Affiliations
Comparative Study

Gender differences in the slow delayed (IKs) but not in inward (IK1) rectifier K+ currents of canine Purkinje fibre cardiac action potential: key roles for IKs, beta-adrenoceptor stimulation, pacing rate and gender

Najah Abi-Gerges et al. Br J Pharmacol. 2006 Mar.

Abstract

As the beagle dog is a commonly used preclinical species to test the effects of new drugs on cardiac repolarisation and Purkinje fibres have become an established in vitro preparation to assess the effects of these new drugs on action potential duration (APD), the main aim of this study was therefore to evaluate the relative contribution of the inward (I(K1)) and slow delayed (I(Ks)) rectifier cardiac K(+) currents to action potential repolarisation in beagle Purkinje fibres under three different experimental conditions: (i) selective block of I(K1) with BaCl(2), (ii) selective block of I(Ks) with (-) chromanol 293B under basal conditions and (iii) selective block of I(Ks) during beta-adrenoceptor stimulation. Furthermore, the dependence of this contribution on gender and pacing rate was investigated. Microelectrode techniques were employed to measure APD in Purkinje fibres from adult female and male dogs. At stimulation rates of 3.33, 1.0 and 0.2 Hz, the degree of prolongation of APD evoked by BaCl(2) (10 microM) was comparable in fibres from female and male dogs. At the same stimulation rates, 10 microM (-) chromanol 293B did not change the APD in fibres from female and male dogs. During beta-adrenoceptor stimulation with 0.1 microM isoproterenol, an APD prolonging effect of (-) chromanol 293B was detected. In the presence of isoproterenol, action potentials in fibres from male dogs get shorter when changing the stimulation rate from 1.0 to 0.2 Hz, while the opposite is seen in fibres from female dogs. This alteration was completely reversed by (-) chromanol 293B. In conclusion, our findings confirm that beta-adrenoceptor stimulation is one condition where there may be an increased role of I(Ks) in action potential repolarisation. Gender differences in the autonomic modulation of I(Ks) could be a contributing factor to the reported increased susceptibility of female hearts to arrhythmias.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of (−) chromanol 293B on APD during β-adrenoceptor stimulation in beagle dog Purkinje fibres. (a) and (b) show representative action potentials recorded in fibres from female (F) and male (M) animals under control conditions, in the presence of 0.1 μM isoproterenol (Iso) with and without 10 μM (−) chromanol 293B (293B) at stimulation rates of 3.33 and 1.0 Hz.
Figure 2
Figure 2
Effect of (−) chromanol 293B on APD during β-adrenoceptor stimulation in beagle dog Purkinje fibres. (a) and (b) show representative action potentials recorded in fibres from female (F) and male (M) animals under control conditions, in the presence of 0.1 μM isoproterenol (Iso) with and without 10 μM (−) chromanol 293B (293B) at stimulation rates of 1.0 and 0.2 Hz.
Figure 3
Figure 3
Effect of (−) chromanol 293B on APD during β-adrenoceptor stimulation in beagle dog Purkinje fibres – a ‘within stimulation rate' analysis (see Methods). (a–c) The mean per cent change in APD90 induced by isoproterenol (Iso) alone or when combined with 10 μM (−) chromanol 293B (293B) during stimulation rates of 3.33, 1.0 and 0.2 Hz in both female (F) and male (M) animals (n=4 for each gender), respectively. NSP>0.05, *P<0.05, **P<0.01.
Figure 4
Figure 4
Effect of (−) chromanol 293B on rate adaptation of the action potential during β-adrenoceptor stimulation in beagle dog Purkinje fibres – an ‘across stimulation rate' analysis (see Methods). (a) The mean per cent change in APD90 induced by isoproterenol (Iso) alone or when combined with 10 μM (−) chromanol 293B (293B) at a stimulation rate of 3.33 Hz in both female and male animals (n=4 for each gender). NSP>0.05. (b) The mean per cent change in APD90 induced by Iso alone or when combined with 10 μM 293B at a stimulation rate of 0.2 Hz in both F and M animals (n=4 for each gender). NSP>0.05, *P<0.05, **P<0.01.

References

    1. ABI-GERGES N., PHILP K., POLLARD C., WAKEFIELD I., HAMMOND T.G., VALENTIN J.P. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes. Fundam. Clin. Pharmacol. 2004a;18:139–151. - PubMed
    1. ABI-GERGES N., SMALL B.G., LAWRENCE C.L., HAMMOND T.G., VALENTIN J.P., POLLARD C.E. Evidence for gender differences in electrophysiological properties of canine Purkinje fibres. Br. J. Pharmacol. 2004b;142:1255–1264. - PMC - PubMed
    1. ANON Committee for Proprietary Medical Products (CPMP). Points to consider: The assessment of the potential of QT interval prolongation by non-cardiovascular medicinal products. The European Agency for the evaluation of medicinal products 1997. London, 17 December. Reference CPMP/ICH/986/96
    1. ANON ICH E14 Note for guidance on the clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs 2005a. London, 25 May. Reference CHMP/ICH/2/04
    1. ANON ICH S7B Note for guidance on the nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals 2005b. London, 25 May. Reference CHMP/ICH/423/02 - PubMed

Publication types

MeSH terms